Skip to main content
EUPATI Open Classroom
  • About
  • Learning Catalogue
  • Fellow Programme
  • FAQ
  • Glossary
  • EUPATI Toolbox
  • Accessibility
    High Contrast Bigger Text
  • Log in

Welcome to EUPATI Open Classroom!

EUPATI Open Classroom is the brand-new e-learning platform developed by EUPATI. 

It features a flexible and on-demand learning catalogue and allow patients, patient representatives and other stakeholders from anywhere in the world to take courses in medicines research and development.

Learn more!

How does EUPATI Open Classroom work?

Easy! You can explore the courses and navigate the website as a Guest (no account needed) or you can  become an official Learner (by registering and creating an account).

Watch the tutorial video for more details.

Questions? Find the Answers!

What is EUPATI?

EUPATI is the European Patients' Academy on Therapeutic Innovation. It's a unique training provider specialized in patient education that offers different training courses and education materials. 

EUPATI is committed to changing the face of patient engagement through patient education.


Learn more!


Skip Custom Sections
Custom Sections

What kind of courses does the platform offer?

Take a look at the Learning Catalogue Overview and explore the available courses on medicines research and development. Also find out more details about how the platform works.

Section 1 Image
Read more!

Ready to start learning?

Participants from anywhere in the world can enrol to EUPATI Open Classroom. Learners can take the courses online on-demand at their own pace and preferred order.

As a guest you can navigate and explore the platform but as register user you will have access to more functionalities and also keep track on your learning pathway.

Section 2 Image
Register!

What our learners say?

This course has been crucial to my advocacy work. It has strengthened my voice as a patient advocate so that I can meaningfully engage with various stakeholders.

Rachel Lynch, Ireland

I believe that patient engagement will lead to patient empowerment and will remain one of the major driving forces for transformational change in health care including prevention, diagnosis and treatment.

Joanna Robaczewska, Poland

I have been provided with tools which give me confidence to assert the patients' voice. Each process examined highlights how a patient advocate can add value.

Maria Piggin, England 

Section 3 Image
More
Skip Marketing Spots
Marketing Spots

EUPATI's 10th Anniversary

 Read our history, what we have achieved and what we do here.

Follow us on social media to see weekly celebrations :

  • Twitter: @eupatients
  • Linkedin: linkedin.com/company/eupati/
  • Facebook: facebook.com/eupati.eu
Read more

Patient Engagement Roadmap

To help you structure your learning pathway, we strongly recommend to check the Patient Engagement Roadmap first. It gives an overview on how the courses of the EUPATI Open Classroom can be reflected and used in practical terms and according to the experience.

More details

EUPATI Connect

EUPATIConnect is a place where both EUPATI Patient Experts and researchers can connect, to create mutually beneficial opportunities and to enhance the future of patient engagement.

Check it now!

EUPATI National Platforms

EUPATI National Platforms bring patient, academic and industry partners together to discuss patient education and patient involvement in medicines research and development (R&D). Working together, National Platforms raise awareness about the important role of patients, and members identify challenges and opportunities for joint action.

Discover your National Platform
Skip Featured glossary entry
Featured glossary entry

Excipient

Pharmaceutical excipients are natural or synthetic substances combined with the active substance in a dosage form. Excipients assist the drug or active substances to be better metabolised or administered. They protect, support or enhance stability or facilitate absorption of the medicine in the body. They may also assist in product identification (e.g. by colour of a tablet/capsule).
View all entries

Patient Engagement Roadmap

The value of patient involvement in medicines research and development is increasingly recognised by all stakeholders. Unfortunately, limited formal documentation of patient involvement activities hampers the sharing of experience and learnings, preventing timely and systematic implementation. 

To overcome that challenge the content of the EUPATI Patient Expert Programme has been developed following the Patient Engagement Roadmap, a process model that provides guidance for patient involvement in the different areas of the medicines R&D process.

Research Priorities
Research Design & Planning
Research Conduct & Operations
Dissemination, Communication, Post-Approval

Research Priorities

High expertise in disease area required

Setting research priorities
- Gap analysis - Early Horizon Scanning - Matching unmet needs with research
- Defining patient-relevant added value and outcomes

Research Design & Planning

High expertise in disease area required

Protocol Synopsis
- Design - Target population

Protocol Design
- Relevant endpoints - Benefit / Risk balance - In-/Exclusion criteria
- Diagnosis procedures - Quality of life and Patient Reported Outcomes (PROs)
- Ethical issues - Data protection - Mobility issues/logistics - Adherence measures

Medium expertise in disease area required

Practical Considerations
- Contractual issues - Travel expenses - Support for family members - Mobility

Patient Information
- Content - Visual design - Readability - Language - Dissemination

Informed Consent
- Content - Visual design - Readability - Language

Fundraising for Research

Ethical Review

Research Conduct & Operations

High expertise in disease area required

Trial Steering Committee
- Protocol follow up - Improving access - Adherence

Information to Trial Participants
- Protocol amendments - New safety information

Investigators Meeting
- Trial design - Recruitment
- Challenges - Opportunities can trigger amendments

Data Safety Monitoring Committee
- Benefit/Risk
- Drop-out issues - Amendments

Medium expertise in disease area required

Study Reporting
- Summary of interim results
- Dissemination in patient community

Dissemination, Communication, Post-Approval

High expertise in disease area required

Regulatory Affairs
- MAA Evaluation - EPAR Summaries - Lay summary of results
- Package leaflets - Updated safety communication

Medium expertise in disease area required

Health Technology Assessment (HTA)
- Assessment of value - Patient-relevant outcomes - Patient priorities

Post-communication study
- Contribution to publications
- Dissemination of research results to patient community / professionals

  • About
  • Learning Catalogue
  • Fellow Programme
  • FAQ
  • Glossary
  • EUPATI Toolbox
    • Accessibility
    High Contrast Bigger Text
    Home

    © 2022 EUPATI

    The EUPATI Open Classroom is supported by the EUPATI Reload project, funded by EIT Health. EIT Health is supported by EIT, a body of the European Union. 

    For more information about EUPATI, please access our website www.eupati.eu or contact us at info@eupati.eu.

    EIT Health logo and EU logo

    Terms & Conditions I Privacy and Cookie Policy


    You are not logged in. (Log in)
    Policies
    Powered by Moodle Workplace
    Help